The prognostic role of non-critical lactate levels for in-hospital survival time among ED patients with sepsis

• Published in: The American journal of emergency medicine 2016-02, Vol.34 (2), p.170-173
• Main Authors: Aluisio, Adam R., MD, Jain, Ashika, MD, Baron, Bonny J., MD, Sarraf, Saman, MD, Sinert, Richard, DO, Legome, Eric, MD, Zehtabchi, Shahriar, MD
• Format: Article
• Language: English
• Subjects: Aged; Biomarkers - blood; Confidence intervals; Emergency; Emergency medical care; Emergency Service, Hospital; Family medical history; Female; Hospital Mortality; Hospitalization; Humans; Infections; Intensive care; Intubation; Kaplan-Meier Estimate; Lactates - blood; Male; Medical records; Middle Aged; Mortality; Prognosis; Retrospective Studies; Sepsis; Sepsis - blood; Sepsis - mortality; Sepsis - therapy; Studies; Survival; Trends
• ISSN: 0735-6757; 1532-8171
• DOI: 10.1016/j.ajem.2015.10.006

Abstract Objective This study describes emergency department (ED) sepsis patients with non-critical serum venous lactate (LAC) levels (LAC < 4.0 mmol/L) who suffered in-hospital mortality and examines LAC in relation to survival times. Methods An ED based retrospective cohort study accrued September 2010 to August 2014. Inclusion criteria were ED admission, LAC sampling, > 2 systemic inflammatory response syndrome criteria with an infectious source (sepsis), and in-hospital mortality. Kaplan-Meier curves were used for survival estimates. An a priori sub-group analysis for patients with repeat LAC within 6 hours of initial sampling was undertaken. The primary outcome was time to in-hospital death evaluated using rank-sum tests and regression models. Results One hundred ninety-seven patients met inclusion criteria. Pulmonary infections were the most common (44%) and median LAC was 1.9 mmol/L (1.5, 2.5). Thirteen patients (7%) died within 24 hours and 79% by ≤ 28 days. Median survival was 11 days (95% CI, 8.0-13). Sixty-two patients had repeat LAC sampling with 14 (23%) and 48 (77%) having decreasing increasing levels, respectively. No significant differences were observed in treatment requirements between the LAC subgroups. Among patients with decreasing LAC, median survival was 24 days (95% CI, 5-32). For patients with increasing LAC median survival was significantly shorter (7 days; 95% CI, 4-11, P = .04). Patients with increasing LAC had a non-significant trend toward reduced survival (HR = 1.6 95% CI, 0.90-3.0, P = .10). Conclusions In septic ED patients experiencing in-hospital death, non-critical serum venous lactate may be utilized as a risk-stratifying tool for early mortality, while increasing LAC levels may identify those in danger of more rapid deterioration.